KARBE FRANK (CIK 1276700) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy PHAT (24,122 shares), Sell CDTX (7,526 shares), Sell CDTX (43,125 shares), Sell CDTX (7,290 shares), Buy PHAT (10,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 24,122 | $0 |
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) | Chief Financial Officer | Sell | 7,526 | $1.7M |
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) | Chief Financial Officer | Sell | 43,125 | $0 |
| 2025-12-12 | Cidara Therapeutics, Inc. (CDTX) | Chief Financial Officer | Sell | 7,290 | $1.6M |
| 2025-06-05 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 10,500 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21